Sangamo Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 09 2020 - 8:30AM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that Sandy Macrae, CEO of Sangamo, will
present a corporate overview at the 38th Annual J.P. Morgan
Healthcare Conference on Thursday, January 16th at 8:30 a.m. PT in
San Francisco.
The presentation will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investors and Media
section under Events and Presentations.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, ex vivo gene-edited cell
therapy, and in vivo genome editing and gene regulation. For more
information about Sangamo, visit www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200109005263/en/
Investor Relations – Global McDavid
Stilwell 510-970-6000, x219 mstilwell@sangamo.com
Media Inquiries – Global Aron
Feingold 510-970-6000, x421 afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Apr 2023 to Apr 2024